The program is funded through fees from drug manufacturers.
“This legislation is critical to the work of veterinarians and animal caregivers across the state and nationwide,” Gardener said in a statement.
“It keeps animals safe the same way that the F.D.A. keeps medicine for people safe,” Gardner spokeswoman Rachel George said. “This is a seal of approval that lets people know that this (drug) has been tested, and that this is a regulated substance and it’s safe to use.”
Without re-authorization of the bill, the F.D.A. would have no authority to collect fees and the program would face funding cuts, she said.
A hearing on the bill will be held in the Energy and Commerce Subcommittee on Health April 9.